This was a prospective, randomized, open-label, blinded end point (PROBE), 30 parallel group study with two treatment arms. A total of 160 outpatients aged 61–75 years entered a 2-week wash-out period ...

Discover comprehensive details about Telmisartan and Hydrochlorothiazide, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it.

Review the side-effects of Telmisartan and Hydrochlorothiazide as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the ...

Telmisartan, hydrochlorothiazide; 40mg/12.5mg, 80mg/12.5mg, 80mg/25mg; tabs. Not for initial therapy. May be substituted for titrated components. BP not controlled on telmisartan 80mg/day: 80mg/12.5mg ...

Increased left ventricular mass (LVM) is an independent risk factor for cardiovascular morbidity and mortality in patients with hypertension. 1 Therefore, left ventricular hypertrophy (LVH) regression ...

Chika E. Okereke, MD; Franz H. Messerli, MD, Department of Internal Medicine, Section on Hypertensive Diseases, Ochsner Clinic and Alton Ochsner Medical Foundation, New Orleans, LA A total of 57% of ...

systolic blood pressure lowering power(x) after 8 weeks of treatment(1) compared to T80/H12.5. In the consecutive follow up trial 639 patients (633 patients evaluated for efficacy) were treated with ...

After one year on telmisartan (Micardis) 80 mg, my 56-year-old patient’s BP is still 180/90 mm Hg. An earlier trial of hydrochlorothiazide (HCTZ) resulted in weight loss, and a previously prescribed ...

Shares of Glenmark Pharma rose 1.7 percent intraday Tuesday after company received USFDA approval for Telmisartan and Hydrochlorothiazide tablets. Glenmark Pharmaceuticals Inc., USA has been granted ...

New data announced today at the Annual European Society of Hypertension (ESH) show that measuring blood pressure in a doctor's office alone does not provide an accurate picture of a patient's blood ...

Boehringer Ingelheim has announced that a new formulation of its blood pressure-lowering drug Micardis is now available in the UK. Boehringer Ingelheim has announced that a new formulation of its ...